This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
In Vivo Assays for Veterinary Vaccine Development
In vivo assays closely align with real-world conditions during animal use. BioVenic provides a range of in vivo assay services, including animal model selection, toxicity studies, immunogenicity assessment, protective studies, vaccine dose optimization, safety assessment, and immunogenicity titer determination. These services aid in evaluating the vaccine's effectiveness against the target disease in animal models, minimizing adverse reactions, and observing its potential for long-term immunological protection.
Our Services
Animal Models
Each veterinary vaccine corresponds to a specific animal species. With a wealth of animal model resources, BioVenic provides high-quality animal models to assess the safety and efficacy of veterinary vaccine samples. Our services include not only the selection and construction of animal models, but also experimental design, animal inoculation, sample collection, and assessments of various biological and immunological indicators.
| Model Animals | Target Animal Models |
|---|---|
| Mice, rats, guinea pigs, and zebrafish. | Dogs, cats, chickens, ducks and larger animals such as pigs, cows, and sheep. |
Fig.1 Environmental factors to be considered in the housing of laboratory animals. (BioVenic Original)
In Vivo Safety Assays
Ensuring veterinary vaccine safety is of utmost importance for the vaccinated animal populations and public health. To facilitate the successful development of your veterinary vaccines, BioVenic offers in vivo safety assay services. We employ model animals and target animals such as dogs, cats, chickens, ducks, pigs, cows, and sheep that closely mimic veterinary pathogenic conditions to evaluate whether vaccine candidates induce adverse reactions in vaccinated animals. In addition, to address different target animals and vaccine types, we provide reproductive safety assessments and offer exclusive live vaccine virulence reversion testing to meet potential research and development requirements.
- Single, Repeat, and Overdose Safety Assessment
- Reproductive Safety Assessment for Pregnant Animals or Egg-Laying Poultry
- Special Assessment for Live Vaccines
In Vivo Efficacy and Potency Assays
BioVenic offers in vivo potency and efficacy assay services for veterinary vaccines. Through testing in target animal models, our professionals comprehensively assess the efficacy of veterinary vaccines in host animal applications, providing a scientific basis for their further optimization and improvement.
- Challenge Study
- Serological Assessment
| Target antigen concentration | Antibody level |
| Strength of immune response | Duration of immune effectiveness |
Why Choose Us?
- High-quality supply of animal models for in vivo assays used in veterinary vaccine development.
- Full range of in vivo assay services for veterinary vaccines, including safety and efficacy assessments.
- Complete experimental protocol design, ensuring accurate and reliable assessment results.
The use of in vivo assays to assess the safety, efficacy, and stability of veterinary vaccines provides a closer approximation to real-world conditions. BioVenic offers a comprehensive range of in vivo assay services for veterinary vaccine development with suitable animal models such as dogs, cats, chickens, ducks, pigs, cows, and sheep. We are committed to improving the health and welfare of experimental animals, and providing them with excellent living conditions and environments. Please don't hesitate to contact us and join us in contributing to the cause of animal health!